Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rifampicin 600mg - injection with diluent - 600 mg - active: rifampicin 600mg excipient: sodium formaldehydesulfoxylate sodium hydroxide water for injection polysorbate 80 water for injection - tuberculosis rifampicin is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug resistant cases. rifampicin should be used in conjunction with at least one other antituberculosis medicine. leprosy rifampicin is indicated in the treatment of multibacillary and paucibacillary leprosy to effect a conversion of the infectious state to a non-infectious state. rifampicin should be used in conjunction with at least one other anti-leprosy drug. methicillin-resistant staphylococcal infections (mrsa) rifampicin can be used as an alternative to vancomycin in the treatment of mrsa. in such circumstances an appropriate companion antibiotic (e.g. fusidic acid) should always be employed. serious staphylococcal infections rifampicin has been used for the treatment of both life-threatening and serious staphylococcal infections. in such circumstances an appropriate companion antibiotic should be employed. brucellosis rifampicin may be used for the treatment of brucellosis. in such circumstances doxycycline should also be used. meningococcal carriers rifampicin is indicated for the treatment of asymptomatic carriers of n. meningitidis to eliminate meningococci from the nasopharynx. (rifampicin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms). haemophilus influenzae rifampicin is indicated for the treatment of asymptomatic carriers of h influenzae and as chemoprophylaxis of exposed children of 4 years of age or younger. other infections infections caused by rifampicin-sensitive microorganisms such as staphylococci, streptococci, n gonorrhoeae, proteus sp., h. influenzae, e. coli and legionella sp. to prevent emergence of resistant organisms, rifampicin should be given with another antibacterial agent to which the organism has been shown to be susceptible.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - rifampicin - powder and solvent for concentrate for solution for infusion - 600 milligram(s) - antibiotics; rifampicin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - isoniazid; pyrazinamide; rifampicin - tablet - 50 /300 /120 milligram(s) - combinations of drugs for treatment of tuberculosis; rifampicin, pyrazinamide and isoniazid

Filipini - angleščina - FDA (Food And Drug Administration)

pfizer, inc. - none - film-coated tablet - 150 mg/75 mg and 400 mg/275 mg/150 mg/75 mg

Namibija - angleščina - Namibia Medicines Regulatory Council

macleods pharmaceuticals ltd - rifampicin bp , isoniazid bp, ethambutol hydrochloride - tablet - each film-coated tablet contains rifampicin bp 150 mg, isoniazid bp 75 mg and ethambutol hydrochloride bp 275 mg

Namibija - angleščina - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - rifampicin, isoniazid , pyrazinamide, ethambutol - tablets - each tablet contains: rifampicin 150mg, isoniazid 75mg, pyrazinamide 400mg, ethambutol 275mg

Namibija - angleščina - Namibia Medicines Regulatory Council

strides arcolab limited - rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride - tablets - each film-coated tablet contains; rifampicin 150 mg, isoniazid 75 mg, pyrazinamide 400 mg and ethambutol hydrochloride 275 mg.

Nigerija - angleščina - NAFDAC (National Agency for Food and Drugs Administration and Control)

rifampicin150mg/isoniazid 75mg/pyrazinamide 400mg/ethambutol 275mg

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - rifampicin 450mg - tablet - 450 mg - active: rifampicin 450mg

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - ethambutol hydrochloride 100mg - tablet - 100 mg - active: ethambutol hydrochloride 100mg excipient: gelatin magnesium stearate methylated spirits opaglos clear na-7150 purified talc quinoline yellow shellac sorbitol stearic acid sucrose - myambutol is indicated for the treatment of pulmonary tuberculosis, primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculous meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculosis of the skin and tuberculous eye diseases.